Introduction: Subcentimeter NSCLC is not always an early-stage disease despite its small tumor size. We investigated the prognostic impact of such cancers on the basis of the findings of thin-section computed tomography (CT).
Introduction
As a result of recent studies conducted to evaluate the correlation of malignant behavior between radiological and pathological findings in lung cancer in Japan, 1,2 radiologically determined nonsolid or part solid lung adenocarcinomas with a ground grass opacity (GGO) component on thin-section computed tomography (CT) have been considered to have a good prognosis, and in most cases their pathologic features are minimally invasive. [3] [4] [5] [6] Traditionally, however, radiologically determined solid lung cancer without a GGO component is still considered to have a highly malignant nature. Moreover, postoperative nodal involvement is found in approximately 15% to 20% of the cases, even in c-T1 lung cancers. [6] [7] [8] Therefore, it should be considered more malignant than nonsolid or part solid tumors.
Meanwhile, because of the rapid advances in radiological modalities, including thin-section CT scan, small-sized and early-stage lung cancers have been detected in our daily practice. 9 In particular, the opportunity to detect subcentimeter NSCLC has been gradually increasing. Tumor size is one of the most evident prognostic factors in a clinical T descriptor. 10 The eighth edition of the tumor, node, and metastasis (TNM) classification of lung cancer has proposed further changes to subclassify tumors less than 1 cm in size as c-T1a. 11 However, even subcentimeter NSCLCs are not always in the early stage, and they sometimes demonstrate nodal metastases and potential spread to locoregional or distant lesions after surgical resection in our daily practice. [12] [13] [14] [15] We have hypothesized that their malignant behavior may also be well related to consolidation status on thin-section CT scan. 16 However, their clinicopathological features, prognosis, and appropriate operative modes remain controversial because of the rarity of surgically resected subcentimeter NSCLC among c-T1a diseases. Hence, in this retrospective study, we aimed to investigate the clinicopathological characteristics and oncological outcomes of subcentimeter NSCLC on the basis of the findings of thin-section CT scan.
Materials and Methods

Study Population
Between 2004 and 2014, we retrospectively evaluated 328 patients with surgically resected c-N0 subcentimeter NSCLC (i.e., with a tumor size of 1 cm). This retrospective study was performed under a waiver of authorization approved by the institutional review board of Juntendo University School of Medicine, Tokyo, Japan.
Radiological Evaluations on Thin-Section CT Scan
For all patients, findings of the preoperative thinsection CT scan were reviewed in detail by the authors (A. H., T. M., and K. S.). Tumor size was determined preoperatively on the basis of thin-section CT scan findings. In addition, all tumors were subsequently evaluated to estimate the extent of GGO by thin-section CT scan with a 2-mm collimation. The solid component was defined as an area of increased opacification that completely obscured the underlying vascular markings. GGO was defined as an area of slight, homogeneous increase in density that did not obscure the underlying vascular markings. 8 The consolidation-to-tumor ratio (CTR) was defined as the ratio of the maximum size of consolidation to the maximum tumor size on thin-section CT scan. 1 Pure GGO tumor was defined as a lung tumor without a solid component (i.e., CTR ¼ 0), part solid tumor was defined as a lung tumor with both a GGO and solid component (i.e., 0＜CTR＜1.0), and pure solid tumor was defined as a tumor showing only consolidation without GGO on thin-section CT (i.e., CTR ¼ 1.0) (Fig 1) . 6, 8, 16 With regard to the clinical nodal assessment, clinical-N0 meant nonenlarged lymph nodes on CT scan. Figure 1 . Typical findings of subcentimeter NSCLC are presented on the basis of the findings of thin-section computed tomography (CT) scan. Pure ground glass opacity (GGO) tumor was defined as a lung tumor without a solid component (i.e., CTR ¼ 0) and part solid tumor was defined as a lung tumor with both a GGO and solid component (i.e., 0＜CTR＜1.0), whereas pure solid tumor was defined as a tumor showing only consolidation without GGO on thin-section CT (i.e., consolidation-totumor ratio [CTR] ¼ 1.0).
Invasive modalities for mediastinal lymph node staging, such as mediastinoscopy or endobronchial ultrasoundguided transbronchial needle aspiration, were used preoperatively when nodal involvement was suspected.
Operation Policy
With regard to the operative modes for subcentimeter NSCLC at our institution, although a major lung dissection with systematic or selective lymph node dissection is warranted for a resectable tumor, 17 the patient is a candidate for limited surgical resection if a tumor shows GGO dominant or pure GGO on the basis of prospective trials to evaluate the feasibility of limited resection for radiologically determined noninvasive lung cancer. 18 Furthermore, intentional segmentectomy with systematic or selective lymph node dissection is now indicated for part solid or pure solid NSCLC 2 cm or smaller in size according to a prospective randomized trial in Japan. 19 Nonanatomical wedge resection was performed for a few patients who were elderly or had a high cardiopulmonary risk.
Histological and Pathological Evaluations
All patients in the present study were reclassified according to the TNM Classification of Malignant Tumours, seventh edition. 10 For the patients with subcentimeter lung cancer, lung adenocarcinoma was classified according to the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society classification as atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma, which was subdivided into lepidic predominant invasive adenocarcinoma and other invasive adenocarcinomas. 20 Pathological pleural invasion was evaluated by Elastica van Gieson staining to assess the presence or absence of preservation of the preexisting elastic layer of the visceral pleura. In addition, pathological lymphatic invasion and vessel invasion were determined by the identification of tumor cells in the lymphatic lumen or vein vessel lumen. To assess lymphatic invasion and vessel invasion, all sections were stained with D2-40 and Elastica van Gieson stain to assess the presence or absence of preservation of lymphatic or vessel invasion.
Follow-up Policy
The routine follow-up evaluation included a physical examination, chest radiography, and blood tests, including measurements of tumor makers, every 6 to 12 months. A chest CT scan was performed periodically after surgical resection. If any symptom or sign of recurrence was observed, further evaluation was performed, including CT, brain magnetic resonance imaging, and 18 F-fluorodeoxyglucose positron emission tomography. Locoregional recurrence was defined as occurrence within the residual same lobe and hilum or mediastinal lymph nodes, and it was essentially diagnosed by cytological or histological confirmation based on biopsy or surgical resection.
Statistics
An unpaired t test or chi-square test was used to compare the factors. Multivariate analysis was performed to identify the significant prognostic factors associated with oncological outcomes by Cox proportional hazards model by using SPSS Statistics 21 (IBM Corp., Armonk, NY). Forward and backward stepwise procedures were used to determine the combination of factors that were essential for predicting the prognosis. When the Cox proportional hazards model was used to determine the significant prognostic factors for overall survival (OS) and recurrence-free survival (RFS), only potential preoperative confounding factors were assessed as variables because no postoperative factor could influence the decision on the surgical modes. Values for OS or RFS were calculated by Kaplan-Meier estimation methods using a log-rank test. The date of surgical resection was set as the starting point and the date of death, date of recurrence, or last date of followup was used as the end point. Reported continuous data are shown as means plus or minus SD for normality. Statistical analysis was considered significant when the p value was less than 0.05.
Results
Clinical Findings
The overall clinicopathological characteristics of the patients are summarized in Table 1 . Of the 328 patients with c-N0 subcentimeter NSCLC, 139 (42%) showed a pure GGO, 123 (37%) showed a part solid tumor, and 66 (21%) showed a pure solid tumor on the basis of the findings of thin-section CT scan (Fig. 1 ). There were significant differences between the three groups with regard to clinical factors such as sex (p < 0.0001), smoking status (p < 0.0001), serum CEA titer (p < 0.0001), and maximum tumor size (p ¼ 0.0101). The indicated operative modes were significantly different depending on the findings on thin-section CT scan, and lobectomy was performed on 64% of patients with pure solid subcentimeter NSCLC despite their small tumor size (p < 0.0001).
Histopathological Findings
Histological examination revealed that 134 of the 139 cases of pure GGO (97%), 99 of the 123 cases of part solid tumor (81%), and 16 of the 66 cases of pure solid tumor (25%) were lepidic predominant lung adenocarcinoma, including AAH, AIS, MIA, and lepidic predominant invasive adenocarcinoma. In addition, of the 66 patients with a pure solid tumor, 35 (53%) had invasive adenocarcinoma despite their tumor's their subcentimeter size (p < 0.0001). Pathological nodal involvement was observed in seven patients, with all cases found exclusively in patients with a pure solid subcentimeter NSCLC (10.6%). Of the patients with nodal metastasis, three had centrally located lesions and four had peripherally located lesions. Furthermore, lymphatic, vascular, and pleural invasion were also more likely to be seen in patients with a pure solid subcentimeter NSCLC (p < 0.0001). Table 2 shows the results of Cox regression analysis of OS and RFS of patients with c-N0 subcentimeter NSCLC based on the clinical covariates. A multivariate analysis revealed that the presence of a GGO component was an independently significant clinical factor in OS and RFS in this cohort (OS: hazard ratio ¼ 0.196, 95% confidence interval: 0.044-0.884, p ¼ 0.0340; RFS: hazard ratio ¼ 0.168, 95% confidence interval: 0.052-0.543, p ¼ 0.0018). When we estimated the OS and RFS on the basis of CTR, the 5-year OS and RFS rates were significantly better for patients with a pure GGO (OS and RFS ¼ 100%) or part solid (OS ¼ 97.5%, RFS ¼ 94.9%) tumor, whereas the rates for patients with a pure solid subcentimeter NSCLC were 87.6% and 79.3% (OS: p ¼ 0.0015; RFS: p < 0.0001), respectively, with a mean follow-up period of 48 months (Fig 2) .
Prognosis
Hence, we evaluated the patterns of lung cancer recurrence on the basis of the findings on thin-section CT scan. Recurrence was observed in 12 patients (3.7%). Of these patients, 10 (15.1%) had a pure solid subcentimeter NSCLC and two (1.6%) had a part solid NSCLC, whereas recurrence was never found in those with a pure GGO tumor (p < 0.0001 [ Table 3 ]). The details of local recurrence were as follows: hilar or mediastinal lymph node recurrence in eight patients, malignant effusion after the wedge resection that was possibly caused by cut-end recurrence in one patient, and ipsilateral inrapulmonary metastasis in one patient. Therefore, the 5-year lung cancer-specific OS and RFS rates were 100% in nonsolid NSCLC and 100% and 97.3% in part solid subcentimeter NSCLC despite their operative modes, whereas those of pure solid subcentimeter NSCLC were 87.8% and 79.3% (p ¼ 0.0002 and p < 0.0001, respectively).
Additionally, we evaluated the oncological outcomes on the basis of operative procedure in 189 patients of part solid and pure solid subcentimeter NSCLC, because postoperative cancer recurrence was observed in these populations. Although a significant difference was not found, the frequency of locoregional recurrence was high in the patients who underwent wedge resection (four of 38 [10.5%]) compared with in the patients who underwent anatomical resection (i.e., lobectomy or segmentectomy) (six of 151 [4.0%]) (p ¼ 0.1070). Regarding the locoregional RFS depending on the operative modes in patients with part solid and pure solid subcentimeter NSCLC, a marginal difference was observed as indicated in Figure 3 . The 5-year locoregional RFS was 92.3% in the anatomical resection (i.e., lobectomy or segmentectomy) arm, whereas that of the wedge resection arm was 86.2% (p ¼ 0.0718).
Discussion
Effect of maximum tumor size has been shown to have an overwhelming impact on the prognosis of lung cancer and is considered to be the most important descriptor in the T component. Furthermore, the proposed eighth edition of the TNM classification of lung cancer suggests that the prognosis of small-sized NSCLCs is evidently different depending on tumor size and recommends further changes to subclassify T1 into T1a (1 cm), T1b (>1 to 2 cm), and T1c (>2 to 3 cm).
11 Even in patients with subcentimeter NSCLC, the malignant behaviors and prognosis are significantly different depending on the findings on thin-section CT scan according to the current retrospective study. Furthermore, postoperative nodal involvement was found in approximately 10% of patients with subcentimeter NSCLC with a pure solid appearance on thin-section CT. Hence, our observations clearly indicate that "tumor size less than 1 cm" indicates neither an early-stage disease nor the absence of tumor spread. When the prognostic impact of subcentimeter NSCLCs is assessed, a thorough distinction between radiological findings of pure GGO, part solid tumor, and pure solid tumor on thin-section CT scan (i.e., the presence or absence of a GGO component) is extremely important from the standpoint of both histopathological and prognostic examinations in this series. An issue regarding subcentimeter NSCLC may be settled, but previous reports did not address the important correlation between presence of GGO and the oncological result in so large a series. The impact of the presence of a GGO component on the oncological results cannot be overemphasized. 16 Therefore, we believe that our result could be one of the clues to the appropriate strategies for treatment of subcentimeter lesions. According to the results of histological evaluation in this study, pure GGO or part solid lesions showed a lepidic predominance more frequently in subcentimeter NSCLCs. Especially in patients with pure GGO subcentimeter NSCLC, 90% of the cancers were less invasive lung adenocarcinomas, including AAH, AIS, and MIA. Moreover, the 5-year OS rate for surgically resected pure GGO was 100%, which should be described clinically as in situ carcinoma. Furthermore, the oncological outcome of radiologically determined part solid subcentimeter NSCLCs was also excellent regardless of their solid component status. Thus, presence of GGO is a strong clinical factor in favorable survival owing to its minimally invasive nature. 16 In contrast, pure solid appearance was significantly associated with a high malignant potential and poor OS even in patients with a subcentimeter NSCLC. Pathological examination demonstrated that more than 50% of the patients with pure solid subcentimeter NSCLC demonstrated invasive adenocarcinomas, which should not be treated as earlystage lesions regardless of their small tumor size. Therefore, meticulous preoperative evaluation of the findings of thin-section CT scan and a thorough distinction based on the presence of a GGO component is really important to predict tumor invasiveness even in these subcentimeter lesions.
Because of the wide variety of tumor aggressiveness based on thin-section CT findings even in small-sized NSCLC (1 cm), controversies still remain regarding the appropriate operative modes for them. [13] [14] [15] 21, 22 Although lobectomy as the definitive standard of surgery was established by the Lung Cancer Study Group trial almost 20 years ago, 17 there has been increasing evidence showing that in selected patients with early-stage NSCLC, anatomical segmentectomy may be oncologically equivalent but potentially less risky and preserves better pulmonary function than lobectomy. 23 It is well recognized that segmentectomy, or even wide wedge resection, may be enough for pure GGO or GGO dominant lesions corresponding to low-grade tumors such as AAH, AIS, or MIA. 18, 24, 25 The results of our study also support this point of view regarding the proper surgical management for subcentimeter NSCLC with a GGO component. In general, we would just follow a solitary pure GGO lesion if the size does not change. Therefore, sublobar resection is considered if a subcentimeter tumor with a GGO component gradually grows or changes density. Some of the subcentimeter pure GGO lesions that required lobectomy were multifocally expressed GGO lesions in a same lobe.
However, it is still unclear whether limited resection may be equally effective in the management of solid dominant or pure solid lesions, which are usually of a more invasive behavior even in the case of subcentimeter tumors. In this study, frequencies of locoregional recurrence in patients with part solid or pure solid subcentimeter NSCLC did not differ significantly between the patients who underwent wide wedge resection and anatomical resection (i.e., segmentectomy or lobectomy); however, operative modes could have an impact on the prognosis and have been found to be associated with the 5-year locoregional RFS in part solid or pure solid subcentimeter NSCLC. These results would be attributed to the insufficient surgical margins or fewer nodal evaluations with the former. Although a consensus has yet to be reached regarding appropriate operative strategies for more radiologically determined invasive subcentimeter NSCLCs, we suggest that anatomical resection with intraoperative lymph node dissection is needed for operable patients with c-N0 solid lesions from the standpoint of a thorough evaluation to confirm occult lymph node metastasis and distinctive management to prevent locoregional recurrence after thoracic surgery. Long-term follow-up policy is also essential, especially for radiological invasive lung cancer regardless of the subcentimeter lesions.
In contrast, we have often encountered a challenging clinical scenario in which medically compromised patients present with a solid tumor requiring radical surgery for a complete resection. In an increasing aging population in which pulmonary insufficiencies and cardiac complications are prevalent, patients with lung cancer who are considered unsuitable for definitive surgical resection may be optimal candidates for limited resection or nonsurgical treatment, including stereotactic body radiotherapy. However, the oncological outcomes of stereotactic body radiotherapy are still dismal for patients with radiologically determined pure solid tumor, 26 possibly on account of the poor locoregional control against such highly invasive tumors. Regarding the treatment mode of subcentimeter pure GGO or part solid lesions, lymph node metastasis is scarcely found 12 and limited surgical resection would be enough as a definitive local control for medically operable patients. 18 Hence, the issue regarding the appropriate use of nonsurgical treatment for small-sized lung cancer may be considered for the medically high-risk patients, and surgical resection is generally needed as a definitive therapy for operable patients to prevent locoregional recurrence.
Of the patients with a pure GGO or part solid subcentimeter NSCLC, some showed invasive adenocarcinoma lesions, which may be a discrepancy between the radiological and histological findings. In addition, less invasive tumors such as AIS or MIA lesions were found in 14% of patients with a pure solid subcentimeter NSCLC, which indicates that the consolidation status is not always a universal factor for subdividing the malignant behaviors. This is because CTR is qualitative evaluation based on thin-section CT findings. The diagnostic impact of maximum standardized uptake value on 18 F-fluorodeoxyglucose positron emission tomography is controversial for subcentimeter NSCLC 27 ; however, it could be a promising tool for quantitative assessment to investigate their malignant potential, especially for pure solid lesions in the future. 13 Furthermore, we should take into account the possibility of noncancerous diseases such as infectious lesions, granulomas, or fibrocalcified lesions when we encounter subcentimeter pure GGO or solid lesions. Among patients with surgically resected persistent pure GGO lesions, there existed an approximately 10% chance of a noncancerous lesion according to the results of prospective study in Japan. 26 We have not evaluated the data to predict granuloma or fibrocalcified lesion, especially in resected solid nodules. However, they are just watched if tumor size does not change because we do not strongly suspect malignant lesions, which are meticulously evaluated on the basis of thin-section CT scan. If otherwise, we could not find the subtle radiological changes, which could become a convincing argument in favor of suspecting malignancy for this tiny lesion.
There are some limitations of this study. Although radiological and histological characteristics differ notably by geographic area, there is no general consensus regarding the optimal method for evaluating the extent of GGO worldwide. In Japan, however, CTR for small-sized NSCLC is estimated primarily on the basis of thin-section CT findings. Because this was a retrospective study, a validation cohort study is required to confirm our conclusion.
In conclusion, the findings of thin-section CT are extremely important when considering the prognosis of subcentimeter NSCLC. The presence of GGO was a strong clinical factor for favorable survival owing to its minimally invasive nature, whereas radiologically determined pure solid subcentimeter NSCLCs should be treated as invasive tumors regardless of their small tumor size.
